| Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis: results from a multicenter retrospective cohort study JJ Lewin, AM Cook, C Gonzales, D Merola, R Neyens, WJ Peppard, ... Neurocritical care 30, 609-616, 2019 | 46 | 2019 |
| Costs associated with productivity loss among US patients newly diagnosed with multiple myeloma receiving oral versus injectable chemotherapy D Merola, C Yong, SJ Noga, KM Shermock Journal of managed care & specialty pharmacy 24 (10), 1019-1026, 2018 | 17 | 2018 |
| Outpatient Reduction Mammaplasty Offers Significantly Lower Costs with Comparable Outcomes: A Propensity Score–Matched Analysis of 18,780 Cases NA Calotta, D Merola, S Slezak, D Coon Plastic and reconstructive surgery 145 (3), 499e-506e, 2020 | 14 | 2020 |
| Impact of displaying inpatient pharmaceutical costs at the time of order entry: lessons from a tertiary care center SJ Conway, DJ Brotman, BL Pinto, D Merola, LS Feldman, RG Miller, ... Journal of hospital medicine 12 (8), 639-645, 2017 | 9 | 2017 |
| Oncology drug effectiveness from electronic health record data calibrated against RCT evidence: the PARSIFAL trial emulation D Merola, J Young, D Schrag, KJ Lin, N Robert, S Schneeweiss Clinical Epidemiology, 1135-1144, 2022 | 8 | 2022 |
| Initial opioid prescriptions predict continued narcotic use: Analysis of 24,594 reduction mammaplasty patients D Merola, NA Calotta, ZA Lu, SD Lifchez, O Aliu, D Coon Plastic and reconstructive surgery 145 (1), 20-30, 2020 | 6 | 2020 |
| Real-world evidence prediction of a phase IV oncology trial: comparative degarelix vs leuprolide safety D Merola, S Schneeweiss, SK Sreedhara, LE Zabotka, K Quinto, ... JNCI Cancer Spectrum 6 (4), pkac049, 2022 | 4 | 2022 |
| The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology D Merola, U Campbell, N Gautam, A Rubens, S Schneeweiss, SV Wang, ... Clinical Pharmacology & Therapeutics 113 (6), 1217-1222, 2023 | 3 | 2023 |
| Advancing an algorithm for the identification of patients with high data-continuity in electronic health records D Merola, S Schneeweiss, Y Jin, J Lii, KJ Lin Clinical Epidemiology, 1339-1349, 2022 | 3 | 2022 |
| An algorithm to predict data completeness in oncology electronic medical records for comparative effectiveness research D Merola, S Schneeweiss, D Schrag, J Lii, KJ Lin Annals of epidemiology 76, 143-149, 2022 | 2 | 2022 |
| Comparison of EHR Data‐Completeness in Patients with Different Types of Medical Insurance Coverage in the United States P Anand, Y Zhang, D Merola, Y Jin, SV Wang, J Lii, J Liu, KJ Lin Clinical Pharmacology & Therapeutics 114 (5), 1116-1125, 2023 | 1 | 2023 |
| The Impact of Longitudinal Data‐Completeness of Electronic Health Record Data on the Prediction Performance of Clinical Risk Scores Y Jin, JG Weberpals, SV Wang, RJ Desai, D Merola, KJ Lin Clinical Pharmacology & Therapeutics 113 (6), 1359-1367, 2023 | 1 | 2023 |
| The effect of performance transparency on adherence to barcode scanning during order preparation in an adult inpatient satellite pharmacy D Merola, JD Hill, S Olumba, R Duncan, V Almuete, KM Shermock Hospital Pharmacy 54 (1), 37-44, 2019 | 1 | 2019 |
| Costs associated with productivity loss among US patients newly diagnosed with multiple myeloma receiving oral versus injectable chemotherapy D Merola, C Yong, S Noga, KM Shermock Blood 130, 3423, 2017 | 1 | 2017 |
| Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA‐2 trial D Merola, J Young, D Schrag, KJ Lin, S Alwardt, S Schneeweiss Pharmacoepidemiology and drug safety 32 (4), 426-434, 2023 | | 2023 |
| The Use of Oncology Electronic Health Record Databases to Assess the Effectiveness of Breast Cancer Treatment D Merola, JK Lin Harvard University, 2022 | | 2022 |
| RCT DUPLICATE-PRONOUNCE L Zabotka, S Wang, SK Sreedhara, D Merola OSF, 2021 | | 2021 |
| HSR20-099: Cost Comparison of PARP Inhibitors in Women With Ovarian Cancer (OC) in the US HealthCare Market A McBride, J Perhanidis, C Gibson, G Wetzstein Journal of the National Comprehensive Cancer Network 18 (3.5), HSR20-099 …, 2020 | | 2020 |
| HSR20-101: Real-World Chemoradiotherapy Use Among Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Retrospective Observational Study MJ Mooradian, K Shermock, D Merola, B Seal, C Yong, L Brannman Journal of the National Comprehensive Cancer Network 18 (3.5), HSR20-101 …, 2020 | | 2020 |
| Abstract QS13: Safety and Financial Outcomes of Breast Reduction Mammoplasty as an Inpatient or Outpatient Procedure: A Propensity-Score Matched Analysis of 18,780 Cases NA Calotta, D Merola, D O’Brien-Coon Plastic and Reconstructive Surgery–Global Open 7 (4S), 110-111, 2019 | | 2019 |
